Coegin Pharma
  • About us
    • Management
    • Board of Directors
  • Our research
    • Platforms
    • Pipeline
    • Projects
      • Hair growth
      • Skin pigmentation
      • Leukemia
      • Myocardial infarction
  • Investor relations
    • Press releases
    • Financial reports
    • Financial calendar
    • The share
      • Shareholders
      • Warrants
    • Presentations
      • Analyses
    • Corporate governance
      • General meetings
      • Auditor
    • IR Contact
    • Archive
      • Offer documents
      • Previous IR Goldblue
  • Media
    • Video presentations
    • Press material
    • Press releases
  • Contact
  • Change language
    • English
    • Svenska

Public offer documents

2019-06-27
GoldBlue: Tillägg till prospekt avseende inbjudan till teckning av aktier i GoldBlue
2019-06-17
GoldBlue: Inbjudan till teckning av aktier i GoldBlue
2018-11-29
GoldBlue: Inbjudan till teckning av Units i GoldBlue
2018-11-29
GoldBlue: Särskild anmälningssedel - Teckning utan företrädesrätt
2018-11-29
GoldBlue: Inbjudan till teckning av Units i GoldBlue - Emissionsfolder
  • Press releases
  • Financial reports
  • Financial calendar
  • The share
    • Shareholders
    • Warrants
  • Presentations
    • Analyses
  • Corporate governance
    • General meetings
    • Auditor
  • IR Contact
  • Archive
    • Offer documents
    • Previous IR Goldblue

Subscribe

Press releases and reports by email.

Subscribe

Receive press releases and reports to your e-mail.

Email Address:

Coegin Pharma AB

Registration number
559078-0465

Address
Coegin Pharma AB
c/o Medicon Village
223 81 Lund, Sweden

Privacy policy

Follow us

Cookie settings

© 2025 Coegin Pharma AB